PPP invests among others in the development of new technology, such as arm robots. Our investments in exoskeleton research has served as a leverage for further financing. To translate the results from academic projects into new devices that really can be used, a company is needed. That is why Yumen Bionics was founded at the end of 2016. Yumen Bionics is developing a new type of arm support for young men with Duchenne. PPP is involved in this initiative as well.